Needs Statement
Despite ongoing advancements in cardiovascular medicine, clinicians continue to face professional practice gaps in the timely adoption and application of emerging technologies and evidence-based strategies. These gaps include underutilization of percutaneous interventions for congenital and valvular heart disease, limited integration of artificial intelligence into clinical workflows, and inconsistent approaches to managing complex conditions such as cardiogenic shock, atrial fibrillation, and genetic aortopathies. Additionally, Advanced Practice Providers (APPs) often lack structured opportunities for leadership development and clinical elevation, which can hinder their ability to contribute fully to interdisciplinary care teams. To address these gaps, the symposium offers a robust educational experience that spans structural heart interventions, complex cases, ambulatory heart failure management, and surveillance strategies for aortic stenosis. Sessions will also explore the role of AI in cardiology, the impact of new device technologies, and the importance of early intervention and guideline optimization. The symposium also provides targeted content for nurse practitioners and physician assistants, emphasizing diagnostic innovation, professional leadership, and collaborative care. This multifaceted approach ensures that participants gain actionable insights to enhance patient outcomes and lead change in cardiovascular practice.

Target Audience
This activity is designed for physicians, physician assistants, nurse practitioners, registered nurses, and other medical care providers who are interested in the latest advances in cardiology. Fellows, residents, and medical students are also welcome to attend.

Educational Objectives
At the conclusion of this activity, the participants should be able to:

• Evaluate recent advances in percutaneous treatments for congenital heart disease, including diagnostic innovations and evolving guideline-based strategies for ambulatory management.
• Analyze paradigm shifts in the treatment of acute heart failure, with emphasis on percutaneous techniques, surveillance strategies, and interdisciplinary approaches to care.
• Explore emerging applications of artificial intelligence in cardiology, recognizing current use cases, limitations, and future directions for clinical integration and decision support.
• Interpret evolving diagnostic and management strategies for valvular and congenital heart disease, including surveillance approaches, guideline updates, and the role of emerging technologies in structural heart interventions.

Educational Methods
Lecture • Case Study • Panel Discussion

Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.